Nebenwirkungen · Onglyza
Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-121471 · Präparat HOS-095365
Adverse reactions reported in ≥ 5% of patients treated with saxagliptin 5 mg and more commonly than in patients treated with placebo or that were reported in ≥ 2% of patients treated with saxagliptin 5 mg and ≥ 1% more frequently compared to placebo from the pooled analysis of five studies of glycaemic control, plus an additional active-controlled study of initial combination with metformin are shown in Table 1.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-05-13T16:50:00Z · SHA-256 b9a937f1b60afa9f56d405cc74d388d5177226d03f89a6727bfbd12cd7681944 · Passage 7893f486de3cf0fb52c57778e629a9017ad544f8c62831cb0a8c298d4fa1bca9 · Zeichen 1315–1730 im Abschnitt